Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced preliminary safety and antitumor data for RMC-9805, ...
Rigel Pharmaceuticals, Inc. ("Rigel") , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced it is issuing a Dear Health Care Provider (DHCP) letter ...
This is part of a series of stories asking candidates for the Carroll County Board of Education to discuss issues important to county residents. Muri Dueppen, Amanda Jozkowski, Greg Malveaux and ...
Tudor Gold is pleased to announce an update to ongoing metallurgical testwork on the Goldstorm gold, copper and silver deposit. Highlights from the Metallurgical Testing on the Lower CS-600 Sub-Domain ...
This study, being conducted in South Africa, is similar to ImmunityBio’s U.S.-based trial QUILT 3.092, a phase 1 open-label study of CD19 t-haNK as a single agent and in combination with the company’s ...